Total Payments
$2,856
2024 Payments
$891.25
Companies
13
Transactions
44
Medicare Patients
2,680
Medicare Billing
$171,860
Payment Breakdown by Category
Food & Beverage$1,751 (61.3%)
Consulting$1,000 (35.0%)
Education$105.85 (3.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,751 | 39 | 61.3% |
| Consulting Fee | $1,000 | 2 | 35.0% |
| Education | $105.85 | 3 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,255 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $903.69 | 16 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $282.58 | 9 | $0 (2024) |
| Amgen Inc. | $122.08 | 1 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $105.85 | 3 | $0 (2024) |
| Celgene Corporation | $62.25 | 3 | $0 (2024) |
| RECORDATI_RARE_DISEASES_INC. | $21.77 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $20.40 | 1 | $0 (2024) |
| PFIZER INC. | $19.16 | 1 | $0 (2024) |
| Stemline Therapeutics Inc. | $15.98 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $891.25 | 23 | AstraZeneca Pharmaceuticals LP ($333.24) |
| 2023 | $674.06 | 14 | Janssen Biotech, Inc. ($383.36) |
| 2022 | $246.94 | 4 | Janssen Biotech, Inc. ($215.50) |
| 2021 | $1,044 | 3 | AstraZeneca Pharmaceuticals LP ($922.09) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: Hematology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $139.89 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.48 | General |
| Category: Hematology | ||||||
| 10/04/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Education | In-kind items and services | $45.27 | General |
| Category: Hematology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.22 | General |
| Category: Hematology | ||||||
| 08/22/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Education | In-kind items and services | $30.29 | General |
| Category: Hematology | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Oncology | ||||||
| 07/27/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Oncology | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Oncology | ||||||
| 05/08/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Oncology | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: Oncology | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $110.59 | General |
| 02/16/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 12/13/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 723 | 1,038 | $235,843 | $52,799 |
| 2022 | 12 | 527 | 773 | $207,851 | $47,435 |
| 2021 | 11 | 570 | 811 | $190,756 | $45,126 |
| 2020 | 19 | 860 | 1,372 | $136,965 | $26,500 |
Total Patients
2,680
Total Services
3,994
Medicare Billing
$171,860
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 424 | $156,032 | $34,208 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 91 | $45,136 | $10,586 | 23.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 17 | 18 | $9,414 | $2,132 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 19 | $4,750 | $1,106 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 108 | $2,160 | $907.20 | 42.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 49 | 61 | $3,660 | $814.96 | 22.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 56 | 73 | $4,672 | $755.55 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 57 | 73 | $2,628 | $555.53 | 21.1% |
| 83550 | Iron binding capacity | Office | 2023 | 50 | 62 | $2,170 | $531.34 | 24.5% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 11 | 12 | $1,716 | $420.36 | 24.5% |
| 83540 | Iron level | Office | 2023 | 50 | 62 | $1,674 | $393.08 | 23.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 15 | 16 | $1,280 | $263.36 | 20.6% |
| 83735 | Magnesium level | Office | 2023 | 12 | 19 | $551.00 | $124.83 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 380 | $139,840 | $31,534 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 82 | $40,672 | $9,827 | 24.2% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2022 | 19 | 20 | $10,460 | $2,500 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 27 | $6,750 | $1,625 | 24.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 35 | 46 | $2,944 | $481.08 | 16.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 44 | 56 | $2,016 | $430.16 | 21.3% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 18 | 19 | $1,140 | $254.51 | 22.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 62 | 79 | $1,580 | $234.27 | 14.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 11 | 11 | $836.00 | $163.78 | 19.6% |
| 83550 | Iron binding capacity | Office | 2022 | 18 | 19 | $665.00 | $163.25 | 24.5% |
| 83540 | Iron level | Office | 2022 | 18 | 19 | $513.00 | $120.79 | 23.5% |
| 83735 | Magnesium level | Office | 2022 | 11 | 15 | $435.00 | $99.89 | 23.0% |
About Leigh Wolfe, NP-C
Leigh Wolfe, NP-C is a Nurse Practitioner healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1720624703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leigh Wolfe, NP-C has received a total of $2,856 in payments from pharmaceutical and medical device companies, with $891.25 received in 2024. These payments were reported across 44 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,751).
As a Medicare-enrolled provider, Wolfe has provided services to 2,680 Medicare beneficiaries, totaling 3,994 services with total Medicare billing of $171,860. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Austin, TX
- Active Since 11/25/2019
- Last Updated 08/04/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1720624703
Products in Payments
- TAGRISSO (Drug) $1,000
- ERLEADA (Drug) $632.86
- MYRISK (Device) $282.58
- DARZALEX (Biological) $139.89
- IMFINZI (Biological) $122.09
- Nplate (Biological) $122.08
- Empaveli (Drug) $105.85
- BALVERSA (Drug) $95.69
- REBLOZYL (Biological) $62.25
- TECVAYLI (Biological) $35.25
- LYNPARZA (Drug) $22.65
- SYLVANT (Drug) $21.77
- Fabhalta (Drug) $20.40
- INLYTA (Drug) $19.16
- Orserdu (Drug) $15.98
- BAVENCIO (Drug) $15.89
- Perjeta (Biological) $15.82
- PADCEV (Biological) $15.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Austin
Mrs. Cecilia Davis, Fnp, FNP
Nurse Practitioner — Payments: $236,137
Nurse Practitioner $236,137
Jordan Harborth
Nurse Practitioner — Payments: $26,729
Nurse Practitioner $26,729
Katiaryna Kulinich
Nurse Practitioner — Payments: $14,772
Nurse Practitioner $14,772
Melissa Sauls, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Nurse Practitioner — Payments: $10,873
Nurse Practitioner $10,873
Mackenzie Taylor, Np, NP
Nurse Practitioner — Payments: $10,224
Nurse Practitioner $10,224
Mrs. Phommalone Nguyen, Fnp, FNP
Nurse Practitioner — Payments: $9,562
Nurse Practitioner $9,562